[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2020 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- -27.72%
YoY- 12.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 3,173,996 2,725,071 2,787,317 2,931,368 3,279,684 2,820,530 2,806,462 8.54%
PBT 126,096 35,793 65,732 90,412 123,520 -191,865 62,145 60.20%
Tax -34,784 -9,524 -21,310 -26,368 -33,860 42,418 -23,097 31.35%
NP 91,312 26,269 44,421 64,044 89,660 -149,447 39,048 76.08%
-
NP to SH 92,544 27,489 45,093 64,756 89,596 -149,219 39,172 77.29%
-
Tax Rate 27.59% 26.61% 32.42% 29.16% 27.41% - 37.17% -
Total Cost 3,082,684 2,698,802 2,742,896 2,867,324 3,190,024 2,969,977 2,767,414 7.45%
-
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 41,872 28,761 34,852 44,409 62,695 22,177 29,557 26.11%
Div Payout % 45.25% 104.63% 77.29% 68.58% 69.98% 0.00% 75.46% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
NOSH 261,705 261,705 261,705 261,705 261,229 261,229 261,229 0.12%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 2.88% 0.96% 1.59% 2.18% 2.73% -5.30% 1.39% -
ROE 26.00% 8.15% 13.07% 18.09% 25.60% -44.33% 7.59% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 1,212.81 1,042.20 1,066.33 1,122.12 1,255.48 1,081.04 1,076.09 8.29%
EPS 35.36 10.51 17.25 24.78 34.28 -57.19 15.01 76.95%
DPS 16.00 11.00 13.33 17.00 24.00 8.50 11.33 25.84%
NAPS 1.36 1.29 1.32 1.37 1.34 1.29 1.98 -22.13%
Adjusted Per Share Value based on latest NOSH - 261,705
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 220.22 189.08 193.40 203.39 227.56 195.70 194.72 8.54%
EPS 6.42 1.91 3.13 4.49 6.22 -10.35 2.72 77.18%
DPS 2.91 2.00 2.42 3.08 4.35 1.54 2.05 26.27%
NAPS 0.247 0.234 0.2394 0.2483 0.2429 0.2335 0.3583 -21.94%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 3.26 5.00 4.32 2.22 1.26 2.06 2.44 -
P/RPS 0.27 0.48 0.41 0.20 0.10 0.19 0.23 11.27%
P/EPS 9.22 47.56 25.04 8.96 3.67 -3.60 16.25 -31.44%
EY 10.85 2.10 3.99 11.17 27.22 -27.76 6.16 45.79%
DY 4.91 2.20 3.09 7.66 19.05 4.13 4.64 3.83%
P/NAPS 2.40 3.88 3.27 1.62 0.94 1.60 1.23 56.08%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 -
Price 4.03 3.49 5.72 4.42 1.88 2.04 2.21 -
P/RPS 0.33 0.33 0.54 0.39 0.15 0.19 0.21 35.12%
P/EPS 11.40 33.20 33.16 17.83 5.48 -3.57 14.71 -15.61%
EY 8.77 3.01 3.02 5.61 18.24 -28.04 6.80 18.46%
DY 3.97 3.15 2.33 3.85 12.77 4.17 5.13 -15.69%
P/NAPS 2.96 2.71 4.33 3.23 1.40 1.58 1.12 91.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment